Wellesley Physician agrees to pay $25,000 to resolve allegations that he violated Controlled Substance Act
BOSTON – A Wellesley plastic surgeon has agreed to pay $25,000 to resolve allegations that he provided controlled substances to family members outside the usual course of his professional practice and failed to maintain records and accurate inventories of controlled substances.
Arthur Shektman, M.D., a plastic surgeon practicing in Wellesley, has agreed to pay $25,000 to resolve allegations that he violated the Controlled Substances Act by dispensing controlled substances outside the usual course of his professional practice and by failing to maintain complete and accurate inventories of controlled substances.
“DEA registrants are responsible for handling controlled substances responsibly and ensuring that complete and accurate records are being properly kept and accounted for in compliance with the Controlled Substance Act,” said Brian D. Boyle, Special Agent in Charge of the DEA Boston Field Division. “We are committed to working with our law enforcement and regulatory partners to ensure that these rules and regulations are followed.”
“The proper handling of prescriptions is a critical part of patient safety and crucial to preventing drug diversion,” said United States Attorney Andrew E. Lelling. “This office will continue to ensure that DEA registrants meet federal recordkeeping requirements, whether they are solo physician practices or large pharmacy chains.”
According to the allegations in the settlement, on two occasions, Dr. Shektman provided controlled substances to two family members outside the usual course of his professional practice. Dr. Shektman also allegedly failed to maintain records pertaining to Schedule II controlled substances and failed to maintain complete and accurate inventories of controlled substances.
Dr. Shektman cooperated with the federal investigation and has agreed to pay $25,000 to resolve the government’s allegations. He has also agreed to enter into a three-year Memorandum of Agreement with the DEA to come into compliance with the recordkeeping requirements of the Controlled Substances Act.
DEA New England Division Special Agent in Charge Brian D. Boyle and U.S. Attorney Andy Lelling made the announcement today.
